XL-protein GmbH

Xl-protein gmbh email format

Verified email-pattern data for Xl-Protein Gmbh is currently limited. You can still use the company insights and contact sections below.
XL-protein develops and commercializes its proprietary clinical-stage PASylation® technology to extend the in vivo half-life of biopharmaceuticals. The genetic fusion (or chemical conjugation) with conformationally disordered amino acid sequences composed of the three small residues Pro, Ala, and/or Ser ('PASylation') provides a simple means to attach a solvated biopolymer with large hydrodynamic volume to a therapeutic protein or peptide. This polypeptide adopts a bulky random coil structure, which significantly increases the size of the biopharmaceutical. By this way the typically rapid clearance of the biologically active component via kidney filtration, or in the eye, is retarded by 1-2 orders of magnitude, depending on the length of the PAS tag. Compared with other strategies to prolong the plasma half-life of biologics PASylation technology offers a genetically encoded biopolymer with precise definition which is biochemically inert while biodegradable in the body.

Company Details

Employees
5
Founded
-
Address
Lise-Meitner-Strasse 30, Freising,d-85354,germany
Phone
+49 (0) 8161 53730-90
Industry
Biotechnology Research
Keywords
Freiburg.
HQ
Freising
Looking for a particular XL-protein GmbH employee's phone or email?

Xl-Protein Gmbh Questions

Explore related pages

Related company profiles:

Top XL-protein GmbH Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant